U.S. Markets open in 9 hrs 9 mins

Talaris Therapeutics, Inc. (TALS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.96-1.88 (-12.67%)
At close: 04:00PM EST
12.96 0.00 (0.00%)
After hours: 04:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 319.82
52 Week Low 311.30
50-Day Moving Average 315.03
200-Day Moving Average 314.53

Share Statistics

Avg Vol (3 month) 351.93k
Avg Vol (10 day) 3102.12k
Shares Outstanding 541.31M
Implied Shares Outstanding 6N/A
Float 814.55M
% Held by Insiders 113.41%
% Held by Institutions 170.65%
Shares Short (Sep 14, 2021) 4779.23k
Short Ratio (Sep 14, 2021) 417.71
Short % of Float (Sep 14, 2021) 43.09%
Short % of Shares Outstanding (Sep 14, 2021) 41.88%
Shares Short (prior month Aug 12, 2021) 4700.12k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -32.51M
Net Income Avi to Common (ttm)-33.85M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)266.22M
Total Cash Per Share (mrq)6.44
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)58.03
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-30.5M
Levered Free Cash Flow (ttm)N/A